APRIL LUCHT: Open Payments
NPI 1336883735 · FREMONT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,871 in 243 payments from 19 companies in 2025. Trend: 2023 $1,929 · 2024 $3,278 · 2025 $3,871
Food & beverage: $3,871
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $608 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 30 | $566 |
| Neurocrine BioSciences, Inc. | 30 | $417 |
| Otsuka America Pharmaceutical, Inc. | 20 | $369 |
| E.R. Squibb & Sons, L.L.C. | 10 | $324 |
| Teva Pharmaceuticals USA, Inc. | 28 | $266 |
| Alkermes, Inc. | 13 | $252 |
| Vanda Pharmaceuticals Inc. | 15 | $242 |
| Axsome Therapeutics, Inc. | 5 | $198 |
| Supernus Pharmaceuticals, Inc. | 20 | $196 |
Products named: VRAYLAR, CAPLYTA, INGREZZA, COBENFY, ARISTADA, ABILIFY MAINTENA, Auvelity, Qelbree.
Industry payments across MI — which companies pay providers there.
